The p53 loss of function in melanomas has been related to reduced cytokine expression, reduced migration and increased sensitivity to BRAF inhibition [30], thus supporting the role of aberrantly accumulated p53 in melanoma malignancy. The gene discussed is TP53; the disease is melanoma.